Irish drug developer signs licensing deal for autoimmune therapies
Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices